{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:32:04Z","timestamp":1793140324662,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["10083165"],"award-info":[{"award-number":["10083165"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eclinm.2026.104116","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:13:03Z","timestamp":1785971583000},"page":"104116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-9886","authenticated-orcid":false,"given":"Thomas A.N.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"de la Torre Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9705-2854","authenticated-orcid":false,"given":"Moona","family":"Razzaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcadio","family":"Garcia de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossen","family":"Alexiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5025-0344","authenticated-orcid":false,"given":"Catalina","family":"Panainte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-7663","authenticated-orcid":false,"given":"Hannah","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Chatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Roser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-3120","authenticated-orcid":false,"given":"Alan","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Nguyen-Van-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"O\u2019Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-7481","authenticated-orcid":false,"given":"Adam P.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-7642","authenticated-orcid":false,"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.eclinm.2026.104116_bib1","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.vaccine.2019.04.001","article-title":"Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: a scoping review of published literature, 2006 to 2016","volume":"37","author":"Charania","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104116_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2375081","article-title":"Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: a health equity perspective","volume":"20","author":"Lubanga","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"10441","key":"10.1016\/j.eclinm.2026.104116_bib3","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.104116_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126648","article-title":"Left out in the cold - inequity in infectious disease control due to cold chain disparity","volume":"45","author":"Talbot","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104116_bib5","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.04004","article-title":"How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): a scoping review of the literature","volume":"11","author":"Dadari","year":"2021","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104116_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41597-022-01167-y","article-title":"Dataset of ultralow temperature refrigeration for COVID 19 vaccine distribution solution","volume":"9","author":"Sun","year":"2022","journal-title":"Sci Data"},{"issue":"20","key":"10.1016\/j.eclinm.2026.104116_bib7","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.vaccine.2007.02.052","article-title":"Freezing temperatures in the vaccine cold chain: a systematic literature review","volume":"25","author":"Matthias","year":"2007","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.eclinm.2026.104116_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18147425","article-title":"The ecological footprint of COVID-19 mRNA vaccines: estimating greenhouse gas emissions in Germany","volume":"18","author":"Kurzweil","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eclinm.2026.104116_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.rser.2021.111400","article-title":"COVID-19 pandemics stage II - Energy and environmental impacts of vaccination","volume":"150","author":"Klemes","year":"2021","journal-title":"Renew Sustain Energy Rev"},{"issue":"23","key":"10.1016\/j.eclinm.2026.104116_bib10","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.vaccine.2017.03.081","article-title":"Economic impact of thermostable vaccines","volume":"35","author":"Lee","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104116_bib11","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.vaccine.2019.11.052","article-title":"An investment case for maternal and neonatal tetanus elimination","volume":"38","author":"Laing","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104116_bib12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3201\/eid2510.190271","article-title":"Global epidemiology of Diphtheria, 2000-2017(1)","volume":"25","author":"Clarke","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"31","key":"10.1016\/j.eclinm.2026.104116_bib13","first-page":"417","article-title":"Diphtheria vaccines: WHO position paper \u2013 august 2017","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"10500","key":"10.1016\/j.eclinm.2026.104116_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(25)01037-2","article-title":"Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.eclinm.2026.104116_bib15","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.vaccine.2023.04.039","article-title":"A thermostable tetanus\/diphtheria (Td) vaccine in the StablevaX pre-filled delivery system","volume":"41","author":"de la Torre Arrieta","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104116_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41541-025-01242-6","article-title":"Overview of vaccines for adults authorized, recommended, and implemented in the European Union","volume":"10","author":"Pattyn","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.eclinm.2026.104116_bib17","series-title":"Health Survey for England 2022: Adult Overweight and Obesity","year":"2023"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104116_bib18","first-page":"53","article-title":"Tetanus vaccines: WHO position paper \u2013 february 2017","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eclinm.2026.104116_bib19","series-title":"Guidelines on clinical evaluation of vaccines: regulatory expectations. Annex 9, WHO Technical Report Series No. 1004","year":"2017"},{"issue":"10249","key":"10.1016\/j.eclinm.2026.104116_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104116_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104116_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciw066","article-title":"Durability of vaccine-induced immunity against tetanus and diphtheria toxins: a cross-sectional analysis","volume":"62","author":"Hammarlund","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600369X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702600369X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:32:11Z","timestamp":1793136731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702600369X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S258953702600369X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104116","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104116"}}